Item 2.02 Results of Operations and Financial Condition.

On August 16, 2021, Acumen Pharmaceuticals, Inc. (the "Company") reported financial results for the quarter ended June 30, 2021. A copy of this press release (the "Earnings Press Release") is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference.

The information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits




Exhibit
  No.                                    Description

99.1          Earnings Press Release, dated August 16, 2021

104         Cover Page Interactive Data File (the cover page XBRL tags are
            embedded within the inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses